Hangzhou Minsheng Healthcare Co Ltd (301507) - Total Liabilities

Latest as of March 2026: CN¥325.04 Million CNY ≈ $47.56 Million USD

Based on the latest financial reports, Hangzhou Minsheng Healthcare Co Ltd (301507) has total liabilities worth CN¥325.04 Million CNY (≈ $47.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Hangzhou Minsheng Healthcare Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Hangzhou Minsheng Healthcare Co Ltd - Total Liabilities Trend (2021–2025)

This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Hangzhou Minsheng Healthcare Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Hangzhou Minsheng Healthcare Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Minsheng Healthcare Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Zhejiang Jiaao Enprotech
SHG:603822
China CN¥6.14 Billion
Changzhou Zhongying Science & Technology Co. Ltd
SHE:300936
China CN¥134.72 Million
Mastek Limited
NSE:MASTEK
India Rs13.17 Billion
QITIAN Technology Group Co Ltd
SHE:300061
China CN¥684.65 Million
Worldline SA
PA:WLN
France €9.10 Billion
Jiangsu Boiln Plastics Co. Ltd.
SHE:301003
China CN¥59.26 Million
Obrascon Huarte Lain SA
MC:OHLA
Spain €2.84 Billion
The Star Entertainment Group Ltd
AU:SGR
Australia AU$1.11 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down Hangzhou Minsheng Healthcare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301507 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.83 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Minsheng Healthcare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Minsheng Healthcare Co Ltd (2021–2025)

The table below shows the annual total liabilities of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥298.60 Million
≈ $43.69 Million
+39.69%
2024-12-31 CN¥213.76 Million
≈ $31.28 Million
+22.32%
2023-12-31 CN¥174.75 Million
≈ $25.57 Million
+2.10%
2022-12-31 CN¥171.16 Million
≈ $25.05 Million
+2.88%
2021-12-31 CN¥166.37 Million
≈ $24.34 Million
--

About Hangzhou Minsheng Healthcare Co Ltd

SHE:301507 China Drug Manufacturers - General
Market Cap
$634.45 Million
CN¥4.34 Billion CNY
Market Cap Rank
#10913 Global
#2957 in China
Share Price
CN¥12.16
Change (1 day)
+0.83%
52-Week Range
CN¥11.45 - CN¥17.79
All Time High
CN¥32.51
About

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin,… Read more